INS and metabolic syndrome: Dyslipidemia, along with endothelial dysfunction, which can also be induced by aberrant insulin signaling, contribute to atherosclerotic plaque formation and myocardial damage generated by at least three different mechanisms: (1) alteration of signal transduction, (2) disturbed regulation of substrate metabolism, and (3) modified substrate delivery to the myocardium [39].